By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TetraLogic Pharmaceuticals 

365 Phoenixville Pike

Malvern  Pennsylvania  19355  U.S.A.
Phone: 610-889-9900 Fax: 610-889-9994


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
TetraLogic Pharmaceuticals (TLOG) Announces Closing Of $47 Million Convertible Senior Notes Offering 6/24/2014 8:56:19 AM
TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $47 Million Offering Of Convertible Notes 6/18/2014 8:49:26 AM
TetraLogic Pharmaceuticals (TLOG) Announces Conference Call With Dr. Marc Pellegrini Of The Walter and Eliza Hall Institute of Medical Research To Discuss Tetralogic Infectious Disease Program 6/13/2014 8:33:36 AM
TetraLogic Pharmaceuticals (TLOG) Announces Preclinical Data Indicating Birinapant's Breadth Of Activity In Models Of Infectious Disease 6/9/2014 9:20:24 AM
TetraLogic Pharmaceuticals (TLOG) To Present Data From Its Clinical Investigation Of SHAPE At The Annual American Society of Clinical Oncology Meeting 5/28/2014 9:55:14 AM
TetraLogic Pharmaceuticals (TLOG) Announces Selection Of Phase 2 Dose For Randomized Clinical Study Of Birinapant In Combination With Azacitidine In Naive Patients With Higher Risk Myelodysplastic Syndromes (MDS) 5/27/2014 9:20:40 AM
TetraLogic Pharmaceuticals (TLOG) To Present At The Bank of America (BAC) Merrill Lynch 2014 Healthcare Conference 5/8/2014 9:23:34 AM
TetraLogic Pharmaceuticals (TLOG) To Present Data From Its Clinical Investigation Of SHAPE At The Annual Society Of Investigative Dermatology Meeting 5/5/2014 9:24:25 AM
TetraLogic Pharmaceuticals (TLOG) To Present At The Deutsche Bank (DB) 39th Annual Healthcare Conference 4/30/2014 9:44:33 AM
TetraLogic Pharmaceuticals (TLOG) Announces Publication Of Structural Characterization Of Birinapant 4/9/2014 8:24:41 AM
12345
//-->